Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Mylan and PAR – NBCNews.com
SAN DIEGO, July 17, 2012 (GLOBE NEWSWIRE) -- Somaxon Pharmaceuticals, Inc. (Nasdaq:SOMX), a specialty pharmaceutical company, today announced that it has entered into separate settlement arrangements with Mylan Inc. and its subsidiary, Mylan ...
Subscribe to LegalLaw247.Com Newsletter